BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15994820)

  • 21. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells.
    Milligan SG; Veerapraditsin T; Ahamet B; Mole S; Graham SV
    Virology; 2007 Mar; 360(1):172-81. PubMed ID: 17098271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sequence analysis of the late region of human papillomavirus type 6 genome].
    Wang M; Zhang MC; Xu XM; Chen LF; Song GX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):568-72. PubMed ID: 12901100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple human papillomavirus types replicate in 3A trophoblasts.
    You H; Liu Y; Agrawal N; Prasad CK; Edwards JL; Osborne AF; Korourian S; Lowery CL; Hermonat PL
    Placenta; 2008 Jan; 29(1):30-8. PubMed ID: 17905430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
    Mistry N; Simonsson M; Evander M
    Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV-16 RNA processing.
    Schwartz S
    Front Biosci; 2008 May; 13():5880-91. PubMed ID: 18508629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 3' region of human papillomavirus type 16 early mRNAs decrease expression.
    Vinther J; Rosenstierne MW; Kristiansen K; Norrild B
    BMC Infect Dis; 2005 Oct; 5():83. PubMed ID: 16225671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.
    Wu C; Kajitani N; Schwartz S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms.
    Nazim M; Masuda A; Rahman MA; Nasrin F; Takeda JI; Ohe K; Ohkawara B; Ito M; Ohno K
    Nucleic Acids Res; 2017 Feb; 45(3):1455-1468. PubMed ID: 28180311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Virological and carcinogenic aspects of HPV].
    Prétet JL; Charlot JF; Mougin C
    Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions.
    Kondo K; Ishii Y; Mori S; Shimabukuro S; Yoshikawa H; Kanda T
    Virology; 2009 Nov; 394(2):259-65. PubMed ID: 19766281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein.
    Kieback E; Müller M
    Virology; 2006 Feb; 345(1):199-208. PubMed ID: 16257028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region.
    Zhao X; Schwartz S
    Virus Genes; 2008 Feb; 36(1):45-53. PubMed ID: 18040766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
    Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
    Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
    Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
    Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downstream sequence elements with different affinities for the hnRNP H/H' protein influence the processing efficiency of mammalian polyadenylation signals.
    Arhin GK; Boots M; Bagga PS; Milcarek C; Wilusz J
    Nucleic Acids Res; 2002 Apr; 30(8):1842-50. PubMed ID: 11937639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues.
    Honoré B; Baandrup U; Vorum H
    Exp Cell Res; 2004 Mar; 294(1):199-209. PubMed ID: 14980514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel human papillomavirus type 16 E1 gene variant with potentially reduced oncogenicity.
    Sabol I; Matovina M; Gasperov NM; Grce M
    J Med Virol; 2008 Dec; 80(12):2134-40. PubMed ID: 19040290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of regulatory motifs within HPV transcripts.
    Cumming SA; Graham SV
    Methods Mol Med; 2005; 119():291-315. PubMed ID: 16350408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.